Interleukin-1 Beta Polymorphisms are Associated with Lymph Node Metastasis in Korean Patients with Papillary Thyroid Carcinoma

REFERENCES

• Arlt, A., Vorndamm, J., Muerkoster, S., Yu, H., Schmidt, W. E., Folsch, U. R., Schafer, H. (2002). Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res. 62(3):910–916.
   PubMed Web of Science ®Google Scholar
• Baune, B. T., Dannlowski, U., Domschke, K., Janssen, D. G., Jordan, M. A., Ohrmann, P., Bauer, J., Biros, E., Arolt, V., Kugel, H., Baxter, A. G., Suslow, T. (2010). The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol. Psych. 67(6):543–549.
   PubMed Web of Science ®Google Scholar
• Berulava, T., Horsthemke, T. (2010). The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur. J. Hum. Genet. 18(9):1054–1056.
   PubMed Web of Science ®Google Scholar
• Carty, C. L., Heagerty, P., Heckbert, S. R., Enquobahrie, D. A., Jarvik, G. P., Davis, S., Tracy, R. P., Reiner, A. P. (2009). Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J. Atheroscler. Thromb. 16(4):419–430.
   Google Scholar
• Chang, Y. W., Jang, J. Y., Kim, N. H., Lee, J. W., Lee, H. J., Jung, W. W., Dong, S. H., Kim, H. J., Kim, B. H., Lee, J. I., Chang, R. (2005). Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int. J. Cancer 114(3):465–471.
   PubMed Web of Science ®Google Scholar
• Coussens, L. M., Werb, Z. (2002). Inflammation and cancer. Nature 420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Czene, K., Lichtenstein, P., Hemminki, K. (2002). Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer 99(2):260–266.
   PubMed Web of Science ®Google Scholar
• Dinarello, C. A. (1996). Biologic basis for interleukin-1 in disease. Blood 87(6):2095–2147.
   PubMed Web of Science ®Google Scholar
• Dinarello, C. A. (2010). Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev. 29(2):317–329.
   PubMed Web of Science ®Google Scholar
• El-Omar, E. M., Carrington, M., Chow, W. H., McColl, K. E., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C. C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J. F., Jr., Rabkin, C. S. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398–402.
   PubMed Web of Science ®Google Scholar
• Enquobahrie, D. A., Rice, K., Williams, O. D., Williams, M. A., Gross, M. D., Lewis, C. E., Schwartz, S. M., Siscovick, D. S. (2009). IL1B genetic variation and plasma C-reactive protein level among young adults: The CARDIA study. Atherosclerosis 202(2):513–520.
   Google Scholar
• Erdogan, M., Karadeniz, M., Ozbek, M., Ozgen, A. G., Berdeli, A. (2008). Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J. Endocrinol. Invest. 31(9):750–754.
   Google Scholar
• Eun, Y. G., Hong, I. K., Kim, S. K., Park, H. K., Kwon, S., Chung, D. H., Kwon, K. H. (2011). A polymorphism (rs1801018, Thr7Thr) of BCL2 is associated with papillary thyroid cancer in Korean population. Clin. Exp. Otorhinolaryngol. 4(3):149–154.
   Google Scholar
• Eun, Y. G., Shin, I. H., Kim, M. J., Chung, J. H., Song, J. Y., Kwon, K. H. (2012). Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population. Surgery 151(2):323–329.
   Google Scholar
• Hahn, W. H., Cho, B. S., Kim, S. D., Kim, S. K., Kang, S. (2009). Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy. Pediatr. Nephrol. 24(7):1329–1336.
   PubMedGoogle Scholar
• Hefler, L. A., Ludwig, E., Lebrecht, A., Zeillinger, R., Tong-Cacsire, D., Koelbl, H., Leodolter, S., Tempfer, C. B. (2002). Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J. Soc. Gynecol. Investig. 9(6):386–390.
   Google Scholar
• Hirankarn, N., Kimkong, I., Kummee, P., Tangkijvanich, P., Poovorawan, Y. (2006). Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J. Gastroenterol. 12(5):776–779.
   Google Scholar
• Ito, H., Kaneko, K., Makino, R., Konishi, K., Kurahashi, T., Yamamoto, T., Katagiri, A., Kumekawa, Y., Kubota, Y., Muramoto, T., Mitamura, K., Imawari, M. (2007). Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol. Rep. 18(2):473–481.
   Google Scholar
• Ito, L. S., Iwata, H., Hamajima, N., Saito, T., Matsuo, K., Mizutani, M., Iwase, T., Miura, S., Okuma, K., Inoue, M., Hirose, K., Tajima, K. (2002). Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/TT relative to CC genotype. Jpn. J. Clin. Oncol. 32(10):398–402.
   Google Scholar
• Jazdzewski, K., Boguslawska, J., Jendrzejewski, J., Liyanarachchi, S., Pachucki, J., Wardyn, K. A., Nauman, A., de la Chapelle, A. (2011). Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J. Clin. Endocrinol. Metab. 96(3):E546–553.
   Google Scholar
• Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., Apte, R. N. (2007). Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res. 67(3):1062–1071.
   Google Scholar
• Landvik, N. E., Hart, K., Skaug, V., Stangeland, L. B., Haugen, A., Zienolddiny, S. (2009). A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer. Carcinogenesis 30(7):1186–1192.
   PubMed Web of Science ®Google Scholar
• Lewis, A. M., Varghese, S., Xu, H., Alexander, H. R. (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4:48.
   PubMed Web of Science ®Google Scholar
• Lewis, C. M. (2002). Genetic association studies: design, analysis and interpretation. Brief Bioinform. 3(2):146–153.
   PubMedGoogle Scholar
• Lin, X. D., Chen, S. Q., Qi, Y. L., Zhu, J. W., Tang, Y., Lin, J. Y. (2012). Polymorphism of THBS1 rs1478604 A>G in 5-untranslated region is associated with lymph node metastasis of gastric cancer in a Southeast Chinese population. DNA Cell Biol. 31(4):511–519.
   Google Scholar
• Liu, J., Zhai, X., Jin, G., Hu, Z., Wang, S., Wang, X., Qin, J., Gao, J., Ma, H., Wei, Q., Shen, H. (2006). Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population. Int. J. Cancer 118(10):2554–2558.
   Google Scholar
• Liu, X., Wang, Z., Yu, J., Lei, G., Wang, S. (2010). Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res. Treat. 124(3):821–825.
   Google Scholar
• Liu, Y. H., Chen, R. H., Wu, H. H., Liao, W. L., Chen, W. C., Tsai, Y., Tsai, C. H., Wan, L., Tsai, F. J. (2010). Association of interleukin-1beta (IL1B) polymorphisms with Graves’ ophthalmopathy in Taiwan Chinese patients. Invest. Ophthalmol. Vis. Sci. 51(12):623–6246.
   Google Scholar
• Maihofner, C., Charalambous, M. P., Bhambra, U., Lightfoot, T., Geisslinger, G., Gooderham, N. J. (2003). Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis 24(4):665–671.
   PubMed Web of Science ®Google Scholar
• Maksymowych, W. P., Rahman, P., Reeve, J. P., Gladman, D. D., Peddle, L., Inman, R. D. (2006). Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum. 54(3):974–985.
   PubMed Web of Science ®Google Scholar
• Motoyama, S., Miura, M., Hinai, Y., Maruyama, K., Usami, S., Saito, H., Minamiya, Y., Satoh, S., Murata, K., Suzuki, T., Ogawa, J. (2009). CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer. Ann. Surg. Oncol. 16(9):2479–2485.
   Google Scholar
• Mukhopadhyay, P., Ali, M. A., Nandi, A., Carreon, P., Choy, H., Saha, D. (2006). The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells. Cancer Res. 66(3):1758–1766.
   Google Scholar
• Nagataki, S., Nystrom, E. (2002). Epidemiology and primary prevention of thyroid cancer. Thyroid 12(10):889–896.
   Google Scholar
• Ozgen, A. G., Karadeniz, M., Erdogan, M., Berdeli, A., Saygili, F., Yilmaz, C. (2009). The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. J. Endocrinol. Invest. 32(6):491–494.
   Google Scholar
• Park, J. K., Lee, S. M., Kang, W. S., Kim, S. K., Cho A. R. (2011). NGF polymorphisms and haplotypes are associated with schizophrenia in Korean population. Mol. Cell. Toxicol. 7(4):375–380.
   Google Scholar
• Solovieva, S., Kamarainen, O. P., Hirvonen, A., Hamalainen, S., Laitala, M., Vehmas, T., Luoma, K., Nakki, A., Riihimaki, H., Ala-Kokko, L., Mannikko, M., Leino-Arjas, P. (2009). Association between interleukin 1 gene cluster polymorphisms and bilateral distal interphalangeal osteoarthritis. J. Rheumatol. 36(9):1977–1986.
   Google Scholar
• Stern, A. G., de Carvalho, M. R., Buck, G. A., Adler, R. A., Rao, T. P., Disler, D., Moxley, G. (2003). Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta. Osteoarthritis Cartilage 11(6):394–402.
   Google Scholar
• Wang, Y. X., Zhao, L., Wang, X. Y., Liu, C. M., Yu, S. G. (2011). Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population. Endocrine 41(3):526–531.
   Google Scholar
• Wolf, J. S., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., Van Waes, C. (2001). IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin. Cancer Res. 7(6):1812–1820.
   Google Scholar
• Wu, S., Lu, S., Tao, H., Zhang, L., Lin, W., Shang, H., Xie, J. (2011). Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer. J. Huazhong Univ. Sci. Technolog. Med. Sci. 31(1):114–119.
   Google Scholar
• Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., Haugen, A. (2004). Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer 109(3):353–356.
   PubMed Web of Science ®Google Scholar